Twitter Beğeni Hilesi

At #ASCO24 Matteo Lambertini, MD PhD presents analysis on BRCA BCY Collaboration including young BRCA carriers affected by eBC: ➡️ Different clinical behavior between BRCA1 and 2 carriers ➡️ Early identification of carriers can lead to improvement in prognosis OncoAlert Università di Genova

16 years have passed since I moved to the US and I continue to be proud of being an IMG! IMG Oncologists Dana-Farber’s Breast Oncology Center

Dose/Exposure Relationship of Exercise and Distant Recurrence in Primary Breast Cancer | Journal of Clinical Oncology ascopubs.org/doi/10.1200/JC… New CANTO data out! Davide Soldato Lee Jones, Unicancer FabriceAndre Antonio Di Meglio, MD, PhD Martina Pagliuca Franzoi Maria Alice Gustave Roussy Cancer Survivorship Group

Our🎲BOC Board Game Night🎲was a huge success! Laughter, great food, and friendly competition made for a fun evening. #WorkFun #GameOn

Check out the #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (July 7th-14th, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch

Does sugar increase cancer risk? Christina Conte, RDN, LDN, nutritionist at Dana-Farber Cancer Institute, helps us debunk myths and clarify the difference between added sugar and naturally occurring sugar. Learn more here: ms.spr.ly/6019lOk4T

A recent Phase II trial, from Dr. Jennifer Ligibel and colleagues, examined the effects of exercise or metformin on myokine concentrations in patients with breast and colorectal cancer. Full text⬇️ pubmed.ncbi.nlm.nih.gov/38887915/ Melinda irwin

Delighted to share the Descriptive paper for the ENICTO Research Consortium. What a great team effort! Exercise and nutrition to improve cancer Treatment-Related outcomes (ENICTO) | JNCI: Journal of the National Cancer Institute | Oxford Academic (oup.com)

#tbt to a cautious celebration Meet Melanie This is the moment 2 years ago that her cancer vanished from scans She died last week This is why we say "remission" or "no evidence of disease" Oncologists may be last to say "cure" before we know every last rogue cell is gone forever

Recently Published📰Mediators of a Mindfulness-Based Intervention for Younger #BreastCancer Survivors: Effects on Depressive Symptoms Read the full text here⬇️⬇️ pubmed.ncbi.nlm.nih.gov/39132946/ #BreastCancerSurvivors Ann Partridge MD, MPH Antonio Wolff, MD (#HealthPolicyIsEconomicPolicy)

The most important component of your medical care is continuity. Nothing else comes close in importance. Find an awesome PCP who is your advocate and rock.

Save the date! SIO is excited to partner with Dana Farber Cancer Institute in hosting the 22nd SIO International Conference in beautiful Boston next year on October 27-29, 2025. #integrativeoncology Dana-Farber’s Breast Oncology Center Ting Bao, MD . Please retweet, make plans and spread the news!

Heading to Barcelona for #ESMO24? Check out some of the sessions and talks featuring Dana-Farber research and expertise.

Intervista alle vincitrici della terza edizione del bando Fondazione Gianni Bonadonna / Fondazione AIRC per la ricerca sul cancro per borse di studio per l’estero, Dr.ssa Chiara Corti e Dr.ssa Caterina Sposetti, MD fondazionebonadonna.org/video/ #fondazionebonadonna #airc #cancer #fundingopportunity #fellowship

Check out this #ESMO24 mini oral session on supportive and palliative care on Sunday where Dr. Jennifer Ligibel will present the results from the #BreastCancer weight loss (BWEL) trial. 🗓️ Sunday, Sept 15th ⏰ 10:15 - 10:20 CEST (4:15 am EST) 📍 Toledo Auditorium - Hall 3

Kudos to Dr. Ligibel's presentation of BWEL phase III trial results at #ESMO24: a 2y telephone-based weight loss intervention significantly increase physical activity habits in overweight women w/ early #BreastCancer (+39.5 min/wk, p=0.0004). Dana-Farber Zakim Center Dana-Farber’s Breast Oncology Center

Here's the #BreastCancer Research Digest - a summary of last week’s publications from select high-impact journals (September 9th-15th, 2024). #ClinicalResearch #CancerTreatment #BCSM #BreastCancerResearch

#ESMO24 our poster by Francesca Ligorio: fasting-mimicking diet+neoadj tx in Early TNBC reduces blood glucose, insulin, LDH levels & fat mass (no sarcopenia!). LDH ↓ predicts pCR (p=0.04). Istituto Tumori IFOM Inhibited intratumor glycosis=novel metabolic biomarker of response?

This is almost beyond imagination. During my oncology fellowship, ppl w/ newly diagnosed metastatic #melanoma lived ~ 6m on avg. Now we have many ppl alive AND cancer-free a decade later. We aren’t done yet, but #ScienceWillWin. Bet. 💪🏆 #OncTwitter #melsm #HistoryofMedicine

Exercise and weight loss data from the BWEL (Breast Cancer Weight Loss) trial presented by Dana-Farber's Jennifer Ligibel, MD, at #ESMO24 shows a significant increase in exercise with a telephone-based weight loss intervention. CC: Dana-Farber’s Breast Oncology Center